Invenio Imaging

About:

INVENIO IMAGING is a privately held corporation

Website: https://www.invenio-imaging.com/

Top Investors: Mission BioCapital, MedTech Innovator, Berkeley Catalyst Fund (BCF)

Description:

INVENIO IMAGING, Inc. is a privately held corporation founded in 2012 based on the research of Prof. Sunney Xie of the Department of Chemistry and Chemical Biology at Harvard University. Invenio is dedicated to developing a fast, reliable, simple-to-use technology for non-destructive microscopic analysis of the molecular make-up of tissues and other materials. INVENIO’s platform technology is positioned to enter the R&D microscopy market, and it is developing instrumentation for several high-value medical applications. INVENIO IMAGING Inc. acknowledges funding from the NSF and NIH SBIR programs.

Total Funding Amount:

$7.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2012-01-01

Contact Email:

contact(AT)invenio-imaging.com

Founders:

Christian Freudiger

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai